Diberdayakan oleh Blogger.

Popular Posts Today

Shortage of meat inspectors not affecting food safety, CFIA says

Written By Unknown on Kamis, 02 April 2015 | 22.45

Comments made this week by the union representing Canada's meat inspectors are unnecessarily undermining confidence in the country's food safety system, says the Canadian Food Inspection Agency.

A news release signed by president Bruce Archibald says the agency is proud that Canada's food safety system has been rated No. 1 out of 17 countries in the Organization for Economic Co-operation and Development by the Conference Board of Canada.

On Tuesday, the Agriculture Union, which represents the CFIA's inspectorate, said a critical shortage of inspectors is putting the safety of consumers at risk across the country.

It said only 12 of 18 meat hygiene inspection positions are filled at processing plants in northern Alberta and staff were
instructed in January to cut sanitation work by 50 per cent.

' A food safety inspector is on the ground at all times in every federally registered meat slaughter plant in Canada'- CIFA

The CFIA says the claims that food safety activities have been cut in northern Alberta are false, adding the number of staff in regions fluctuates due to changes in demand for service.

The news release says the nature of inspection work focuses on areas of highest risk, which can include regional emergencies and enforcement action.

The union suggested the agency and the federal government were more committed to exports, noting all meat destined for the United States comes from plants that are inspected every 12 hours that they are open.

NDP agriculture critic Malcolm Allen said the government is creating a two-tiered food inspection system: one for domestic meat and one for meat bound for export.

The agency says differences in meat inspection systems between the U.S. and Canada are related to trade standards, not food safety.

"Whether it's federal or industry staff, a food safety inspector is on the ground at all times in every federally registered meat slaughter plant in Canada," says the news release.

"A comprehensive system of inspection tasks are routinely carried out in federally registered meat processing plants."


22.45 | 0 komentar | Read More

Should your home DNA test results be private?

Curious about what your DNA might say about your medical future? Genetic tests may tell you if you are more likely to get sick, but taking the tests could expose you to risks you weren't expecting.

While an increasing number of test kits allow you to screen for diseases in the privacy of your home and send your samples by mail, there's little protection if you want to keep those results private.

Unlike other countries including the U.S., U.K., and Japan, Canada has no legislation that protects you from having to disclose your test results to employers and insurance companies, despite a promise by the federal government in 2013 to introduce protective measures.

And a bill currently before the Senate has lost some of its key protections, including prohibiting anyone from forcing you to take a genetic test or reveal the results.

DNA tests

Home DNA tests screen for your risk of getting a variety of illnesses, but you may have to share results with an insurance company or employer. (CBC)

"Canada is one of the only countries in the western world that doesn't have laws to protect the integrity of your genes," Senator James Cowan, the Nova Scotia Liberal who introduced the bill, told CBC Marketplace co-host Erica Johnson.

"There's nothing to prevent an employer or an insurer or anybody else providing any other kind of service, about saying, 'Have you ever had a genetic test? And if so, what are the results of that test?'" he said.

Marketplace investigated home genetic testing kits and found that kits screened for a limited number of diseases and the results and some of the interpretation varied widely between tests from different companies.

  • Watch the full investigation, Gene Genie, Friday, April 3 at 8 p.m. (8:30 p.m. in Newfoundland and Labrador) on CBC TV and online.

'Jolie effect'

Genetic testing looks at DNA taken from saliva or blood, screening for markers associated with an increased risk of diseases or conditions such as heart disease or cancer.

Genetic screening is becoming increasingly mainstream, and greater awareness is fuelling interest, sparked in part by Angelina Jolie's public disclosure of her genetic risk for developing breast and ovarian cancer.

In 2013, Jolie wrote about her decision to have both her breasts removed, and in 2015, she spoke out about a similar decision to have her ovaries removed. Genetic testing revealed that Jolie carries the BRCA1 genetic mutation, putting her at an 87 per cent risk of developing breast cancer and a 50 per cent risk for ovarian cancer, according to her op-ed article in the New York Times.

In addition to screening by a doctor or at a hospital, direct-to-consumer tests have become popular options, with most home kits from companies like 23andMe and EasyDNA costing between $200 and $500.

Information important to assess risk

But you might not realize that if you have genetic testing done, you may be obligated to reveal that information to your insurance company.

Cowan

"This is not about asking about your current medical situation. We're talking about testing that would indicate to you the likelihood that you might sometime in the future develop a particular condition or disease." says Senator James Cowan. (CBC)

According to the Canadian Life and Health Insurance Association (CLHIA), "Where genetic testing has been undertaken and a person is aware of the results and subsequently applies for insurance, the insurer needs to be made aware of relevant and material information derived from the test in order to properly assess the risk."

A CLHIA position statement continues, "This policy is based on the general principle that an insurance contract is a 'good faith' agreement. Both parties have an obligation to disclose any information that may be relevant to the contract so that it can be entered into on an 'equal information' basis."

But whether home DNA test kit results must be disclosed is less clear.

The association declined to be interviewed for the Marketplace investigation.

In a statement, Wendy Hope, CLHIA vice president, wrote: "Direct-to-consumer (DTC) tests are relatively new and each company is working to assess their reliability as they encounter them during the underwriting process. We have not developed an industry position on the value of such tests."

'Instances of genetic discrimination'

Cowan introduced the Senate bill, "An Act to Prohibit and Prevent Genetic Discrimination," in 2013. The bill would prohibit any entity from forcing someone to undergo genetic testing as a condition of getting a job or receiving a service, or from forcing individuals to reveal test results.

The bill also would amend the Canadian Human Rights Act to protect individuals from genetic discrimination.

DNA helix

If you have genetic testing done, you may be obligated to reveal that information to your insurance company when applying for a new policy, says the Canadian Life and Health Insurance Association. (CBC)

Later that year, in the Speech from the Throne, the federal government committed to introduce measures to "prevent employers and insurance companies from discriminating against Canadians on the basis of genetic testing." The government has not yet introduced any new legislation.

Cowan's bill now would protect only federal employees, because the Senate's Conservative majority removed most of its key provisions.

It would not protect most Canadians from having to  reveal results to employers or insurance companies.

"People should be able to make a choice about whether or not to get genetically tested without worrying about whether it's going to have an effect on their insurability or employability," Cowan said.

"I think there are instances of genetic discrimination in Canada, both with respect to employment and insurance. And we're the only major country in the Western world that doesn't have some sort of protection," he said.

"This is not about asking about your current medical situation. We're talking about testing that would indicate to you the likelihood that you might sometime in the future develop a particular condition or disease."

"People should be able to make a choice about whether or not to get genetically tested without worrying about whether it's going to have an effect on their insurability or employability."


22.45 | 0 komentar | Read More

Why suicide-prevention monitoring should last longer

Most suicides in an almost nine-year Ontario study occurred after a first attempt, pointing to the need for longer-term monitoring, doctors say in a new report published Wednesday.

The study tracked more than 65,000 children and adults between April 2002 and December 2010 who went to an emergency department in the province for a first self-poisoning. It compared them with controls of the same age and sex. 

Suicide is the second-leading cause of death among people aged 15 to 35, according to Statistics Canada.

Over an average of five years of follow-up, 976 people out of the 65,784 or nearly 1.5 per cent of those who were discharged for a first poisoning eventually took their own lives, the researchers reported in Wednesday's issue of JAMA Psychiatry.

Their risk of suicide was 40 times higher than the general population, according to what Sick Kids calls the largest suicide prevention study worldwide.

Suicide prevention focuses on the immediate post-attempt period, but the facts suggest the success is limited. In the U.S., suicide rates have increased by more than 16 per cent during the past decade, the researchers said.

High-risk group

"Because the suicide risk is durable over many years after the first attempt, we believe the prevention initiatives should be sustained over many years," said Dr. Yaron Finkelstein, lead author of the study, an associate professor of pediatrics, pharmacology and toxicology at the University of Toronto and a staff physician at the Hospital for Sick Children.

The implication is that suicide prevention efforts such as offering psychiatric resources should be sustained among the high-risk group of people who survived a first self-poisoning, said the study's senior author, Dr. David Juurlink, head of clinical pharmacology and toxicology at Sunnybrook Health Sciences Centre in Toronto.

Self-poisoning "may not just be a one-time event," Finkelstein said. "It may signify the way that they're managing their stresses in life generally, and that's probably why the risk is durable over many years."

Alicia Raimundo, a mental health advocate in Toronto who herself first had thoughts of suicide at age 12, sees the value of longer monitoring.

She told CBC News that for her, "it got to point where walls were up so high around me nobody knew who I was any more. That's when I really started to realize how upset I was and how sad I was.That was the first time I started to think about suicide."

Felt ashamed

After a suicide attempt, Raimundo was at a care centre when another client handed her a silver necklace with "hope" on it. 

"I promised a lot of care people I was going to get support, but I didn't, because I just felt really ashamed about needing that," she said.

In university, she said, she realized the value of therapy, in part through the support of her friends and family.

For her, the message from the research findings lie in finding the best ways to engage in care through therapy, medication and appropriate check-ins.

Lowering suicide rates in Canada requires continuing, high-quality mental health care where the research shows the risk is "exceedingly high" — among those who have a mental illness and who have attempt suicide, ​said Dr. Stan Kutcher, professor of psychiatry at Dalhousie University in Halifax and a recognized expert in suicide.

"We will save lives, very importantly," Kutcher said.

"We will also save people being admitted to hospital with an attempt that did not lead to death, so we will save that chaos in their lives and in the lives of their families. … We will also save money in the health-care system."

The study was funded by the Canadian Institutes of Health Research and the Ontario health ministry's Institute for Clinical Evaluative Sciences.


22.45 | 0 komentar | Read More

Fetal DNA blood test for Down syndrome more accurate but exceptions exist

CHINA/

Current screening for Down syndrome involves an earlier blood test and an ultrasound. ( REUTERS/Carlos Barria)

A DNA-based blood test appears to be more effective in detecting possible Down syndrome in fetuses than standard screening methods for the genetic disorder, researchers say.

The test exhibited perfect accuracy in a clinical trial, detecting Down syndrome in all 38 women whose children had inherited the disorder, the researchers report in the April 2 issue of the New England Journal of Medicine.

By comparison, standard screening methods only detected Down syndrome in 30 of the 38 expecting mothers, the study authors said.

In the test, clinicians analyze fetal DNA circulating freely in a pregnant woman's bloodstream. Greater quantities of fetal DNA — also called cell-free DNA — in a woman's blood are an indication that her fetus has Down syndrome, the researchers said.

"It is clearly a better test than what we're currently using," said study lead author Dr. Mary Norton, a professor and vice chair of clinical and translational genetics at the University of California, San Francisco. "If one is looking at screening specifically for Down syndrome, there's no question this test is better for that purpose."

Despite its accuracy, experts warn that mothers should follow up any positive result with an invasive diagnostic test such as amniocentesis before making any decisions regarding their pregnancy.

"Nobody wants a needle in their uterus when they can get a blood test, but that's just not the way it works in 2015," said Dr. Joe Leigh Simpson, senior vice president of research and global programs at the March of Dimes. "This [new test] is a major advance, but you're still going to have to confirm the results."

Simpson compared a positive result in a cell-free DNA test to a positive cancer screen. "We're not going to be treated for cancer on the basis of an X-ray. We're going to have a biopsy to find out what the situation actually is," he said.

Down syndrome occurs when a baby has an extra copy of chromosome 21 in its DNA. The birth defect can cause physical and intellectual disabilities, as well as lifelong health problems.

Up to now, screening for Down syndrome has involved an earlier blood test and an ultrasound, the U.S. Centers for Disease Control and Prevention says. The blood test looks for patterns of various substances in a mother's blood that are associated with chromosomal problems that lead to Down syndrome, while the ultrasound examines the fetus for indications of birth defects.

The new clinical trial compared this screening method to the cell-free DNA screening test, which takes place at 10 to 14 weeks of pregnancy and has been available since 2011.

Earlier studies of cell-free DNA screening focused on older women believed to be at higher risk for birth defects, but this trial followed more than 15,000 women with an average age of 31. One-quarter were over 35, the age at which women traditionally have been considered high risk.

Besides its strong accuracy, the cell-free DNA test also had a much lower false-positive rate than standard screening -- 0.06 per cent versus 5.4 per cent with standard screening, the study authors said.

"There's no question that cell-free DNA for screening for Down syndrome is a better mousetrap," Simpson said.

The test does have drawbacks, however.

Because it is focused specifically on Down syndrome, the cell-free DNA screening test can overlook indications of other types of birth defects detected by traditional screening methods, Norton said.

The test also won't work properly for pregnant women without enough fetal DNA floating in their bloodstream.

Obese women, in particular, are less likely to have enough free-floating fetal DNA, Norton said.

The test also can be fooled if a mother has an excessive amount of fetal DNA from some other source, like an undiagnosed cancer or a twin that has died in utero, Simpson said.

Sara Weir, president of the National Down Syndrome Society, noted an even broader concern with both the cell-free DNA test and other blood screening tests for birth defects — they aren't regulated by the U.S. Food and Drug Administration, but by an arm of the Centers for Medicare and Medicaid Services.

"The FDA is the gold standard for regulating drugs, diagnostics and other devices, and we would like to see these tests regulated by the FDA," Weir said. "We are worried that women are going to make decisions on maintaining their pregnancy based on false positives. It needs to be better regulated."

The clinical trial was funded, in part, by Ariosa Diagnostics, manufacturer of a cell-free DNA prenatal screen.

Copyright 2011 HealthDay. All rights reserved.


22.45 | 0 komentar | Read More

Acetaminophen for back pain brings no benefit, review concludes

Written By Unknown on Rabu, 01 April 2015 | 22.45

95679289

Low back pain is a common reason for missed work time. (Evgeny Atamanenko/Shutterstock)

​​The commonly-prescribed drug acetaminophen or paracetamol does nothing to help low back pain, and may affect the liver when used regularly, a large new international study has confirmed.

Reporting in today's issue of the British Medical Journal researchers also say the benefits of the drug are unlikely to be worth the risks when it comes to treating osteoarthritis in the hip or knee.

"Paracetamol has been widely recommended as being a safe medication, but what we are saying now is that paracetamol doesn't bring any benefit for patients with back pain, and it brings only trivial benefits to those with osteoarthritis," Gustavo Machado of The George Institute for Global Health and the University of Sydney, tells the Australian Broadcasting Corporation.

"In addition to that it might bring harm to those patients."

Most international clinical guidelines recommend acetaminophen as the "first choice" of treatment for low back pain and osteoarthritis of the hip and knee.

However, despite a trial last year questioning the use of acetaminophen to treat low back pain, there has never been a systematic review of the evidence for this.

Machado and colleagues analyzed three clinical trials and confirmed that acetaminophen is no better than placebo at treating low back pain.

An analysis of 10 other clinical trials by the researchers quantified for the first time the effect acetaminophen has on reducing pain from osteoarthritis in the knee and hip.

"We concluded that it is too small to be clinically worthwhile," says Machado.

He says the effects of acetaminophen on the human body are not well understood and just because it can stop headaches, it doesn't mean the drug will work in all circumstances.

"There is probably a difference in the pain mechanisms in low back pain and osteoarthritis, compared to headache," says Machado.

Liver effects

Importantly, the new study was the first to show that patients using acetaminophen for low back pain and osteoarthritis were nearly four times more likely than those taking placebo to have abnormal results on liver function tests.

Machado says it's unclear whether this means acetaminophen could cause liver damage in the long term.

"But if you see elevation of enzymes in the short term, it's a concern for the long term," he says.

Machado and colleagues point to another recent study suggesting acetaminophen raises the risk of cardiovascular, gastrointestinal and renal disease. They argue doctors should reconsider their recommendation that patients use the drug for low back pain and osteoarthritis of the hip or knee.

Keep active advice

"It's time the clinical guidelines are reviewed," says co-author of the new study associate professor Manuela Ferreira. "Paracetamol shouldn't be included in the guidelines for back pain."

When it comes to treating osteoarthritis, Machado and Ferreira call on doctors to explain the actual risks and benefits.

"If you ask me it's not worthwhile," says Ferreira.

Ferreira says anti-inflammatories are the second choice of treatment for low back pain but they have greater side- effects.

The researchers say other non-drug treatments recommended in the clinical guidelines should be used instead.

These include reassuring patients that low back pain is generally benign and that the best remedy is to keep active. Exercise, strength training and weight management have been shown to be effective in treating osteoarthritis of the hip and knee," says Machado.

Arthritis Research UK also said physical activity is probably a better and more effective way of keeping the pain of arthritis and joint pain at bay than taking painkillers.  

The arthritis group said it's been known for some time acetaminophen may not work for everyone with severe pain from their arthritis, but some people find it allows them to sleep and to exercise without discomfort.

Low back pain and other musculoskeletal conditions account for one-third of missed work time in Canada.


22.45 | 0 komentar | Read More

Most hockey helmets fail new safety evaluation

Most hockey helmets on the market weren't adequate to reduce the risk of head injuries when an experimental new measurement was used.

When researchers at Virginia Tech's biomedical engineering and mechanics department bought and tested 32 helmets under various impacts, one helmet earned three out of five stars, a "good" rating.

There is no concussion-proof helmet, the researchers stressed. The aim is to have helmet manufacturers lower head acceleration and reduce the risk and number of concussions a player suffers over a season, said study author Stefan Duma, head of Virginia Tech's department of biomedical engineering.

A total of 25 out of 33 helmets tested failed to achieve an "adequate" rating of two stars out of a possible five.

The university's findings included:

  • 1 helmet earned three stars, or "good" — the Warrior Krown 360 ($79.98 US).
  • 6 helmets earned two stars or "adequate" ($34.99 to $159.99 US).
  • 16 helmets earned one star ($26.98 to $269.99 US).
  • 9 helmets earned no star ($39.99 to $119.99 US).
King George kids Howe 3

Cost had no correlation with a helmet's safety rating in the new tests. (CBC News)

The Hockey STAR (summation of tests for the analysis of risks) formula was designed to evaluate helmets based on the rotational acceleration that occurs when the head turns on impact, as well as linear acceleration, or motion in the direction of the impact. Concussion is more related to rotational acceleration, neurosurgeons say.

Currently, helmets and helmet safety standards are designed to protect against injuries such as skull fractures. But better designs are possible, said Duma.

"They are what we took from the football world, where they are a little bigger, they have a larger offset, they have a different style of padding," Duma said. "We're going to be interested to see the consumer acceptance of that, but it is very much possible."

Cost had no correlation with a helmet's safety rating.

The best way to consider the differences in helmets is by acceleration, Duma said.

The STAR formula considers level of impact, which is not the way helmets are currently certified, Alan Ashare, president of the Hockey Equipment Certification Council, told CBC News. Ashare said the council is interested in the research.

Discussing the report in an interview with CBC News, sports medicine physician Dr. Paul Echlin, of Burlington, Ont., stressed the value of educating young players and enforcing non-contact play to reduce impacts.

Changing player behaviour, such as enforcing elbowing penalties, reduces the number of times a player is hit and the likelihood of sustaining a concussion, said Mike Oliver, executive director of the National Operating Committee on Standards for Athletic Equipment.

The independent U.S. group does research and recommends improvement in sports equipment.

Blaine Hoshizaki, chair of the International Standard Committee for ice hockey equipment in Ottawa, took issue with how the measurements were made in the study, suggesting the lab tests don't replicate the variety of impacts encountered in an actual game.

CSA-approved helmets were developed to prevent major fractures and lethal bleeds, Echlin said. But the relationship between helmet design and concussions is unknown.

Hockey Canada spokesman Francis Dupont said it will continue to monitor new research and rely on the expertise of those involved with helmet quality control and the companies responsible for manufacturing helmets.


22.45 | 0 komentar | Read More

Health Canada willing to ease fecal transplant rules for recurrent C. difficile

Health Canada has signalled it is willing to loosen the rules on the use of fecal transplants to treat persistent C. difficile infections.

Up until now people who wanted to undergo a fecal transplant to try to cure a recurrent Clostridium difficile infection had to be part of a clinical trial.

HealthMatters Fecal Transplants 20120206

Studies have suggested fecal transplants cure about 90 per cent of recurrent C. difficile cases, like Susan Dunn's of North Bay, Ont. (Brian Tremblay/Canadian Press)

But in new guidance posted online on Monday, the federal regulatory agency said it is open to allowing the treatment to be used outside of clinical trials — a move which proponents suggest may encourage more doctors to do the procedure.

The department has given interested parties 30 days in which to comment on the proposed new position, which will be in effect during the consultation period. A final position will be issued after the submitted comments are reviewed.

Dr. Michael Silverman, who has performed about 50 of the procedures, lauded the federal agency's move.

"This is somewhat brave," said Silverman, chief of infectious diseases at Western University in London, Ont.

"I have empathy for Health Canada on this. They're trying to wade between what's reasonable and what's legalistic. And they are trying to lean on the side of being reasonable and not have what's legalistic get in the way of people who really are suffering and need help."

Recurrent C. difficile infection is a miserable disease that results when the bacterial balance of a person's gastrointestinal tract is knocked out of whack after exposure to antibiotics. In addition to killing whatever bacterium the drugs were targeting, they also kill healthy bacteria which help to maintain a balance in the gut. That allows C. difficile to flourish and take over, causing persistent diarrhea.

Some cases can be cured by using stronger antibiotics. But even then some people cannot clear the infection. Some eventually have to have their colons removed.

Fecal transplants attempt to re-establish a balance in the gut by reintroducing healthy bacteria in the form of stool from a healthy volunteer. The treatment is delivered either through a reverse enema, or is dripped into the gastrointestinal tract in a tube inserted through a nostril.

Studies have suggested fecal transplants cure about 90 per cent of recurrent C. difficile cases — a virtual home run in medicine.

While people who have never had C. difficile may find the procedure repugnant, many who have struggled with debilitating diarrhea literally beg for the treatment from the few physicians who will perform it — people like Silverman or Dr. Christine Lee, a researcher at McMaster University in Hamilton, Ont., who has done more than 400 fecal transplants.

Lee said the new guidance from Health Canada is helpful, and will probably lead more people to do this work.

"I think if they can identify appropriate donors and microbiology laboratory facilities where they're willing to prepare [the transplant], then certainly. But that's not going to be the case for certainly a lot of community hospitals. I think there might still be barriers," she said.

Some laboratories have been reluctant to prepare the donor stool for transplant, Lee noted. And liability concerns may have dissuaded some doctors or hospitals from providing the treatment.

The Health Canada guidance says the donor stool must come from one person, known either to the recipient or to the treating physician. Donors must be screened for relevant infectious disease such as HIV and hepatitis. The guidance says a number of other infectious diseases "may" also be screened for, which Silverman described as a sensible approach.

He suggested Health Canada's move may make the fecal transplant situation in Canada safer. If the procedure is easier to get from the medical community, people will be less likely to try a do-it-yourself transplant at home.

Silverman doesn't believe these procedures have to be done in hospitals, but says it could be dangerous if people used stool from a donor who has not been screened for transmissible diseases.


22.45 | 0 komentar | Read More

Meat sold in Canada not inspected as well as exports: union

Cuts to Canada's food inspection programs have created a "double standard," where meat sold to Canadians is not as well inspected than that destined for export, according to the union that represents inspectors.

"These are more than just numbers on paper," Agriculture Union president Bob Kingston said.

"Lives are at risk, [there's] the real likelihood that people will die. And I hope they wake up to this."

'It's all about money, or rather, the lack of it.'- Marianne Hladun, Public Service Alliance of Canada

At a news conference in Edmonton today, Kingston said since January, the Canadian Food Inspection Agency (CFIA) has quietly rolled back inspections at meat plants in northern Alberta. Increased inspections were put in place following a 2008 listeriosis outbreak tied to Maple Leaf Foods products, which resulted in 22 deaths.

"There's no public debate. There isn't even an industry debate about what's going on. It's the rollback of those commitments to protect Canadians," he said.

He said the CFIA has cut the presence of inspectors in facilities from five days a week to three – but only in plants that produce meat for the domestic market. The presence of inspectors in plants inspecting for export have stayed the same.

"With available resources that CFIA has, the only way they can meet American inspection standards in order to maintain access to the U.S. market is to shortchange inspection of meat for Canadian consumers," Kingston said.

"It's really that simple."

Lilydale under reduced inspections

The news conference was held less than a week after the CFIA announced a recall of chicken products in Western Canada and Ontario over fears of Listeria contamination.

Marianne Hladun, a vice-president with Public Service Alliance of Canada, said the chicken came from an Edmonton Lilydale plant, which was one of the facilities with reduced inspections 

sylvain Charlebois

Food safety expert Sylvain Charlebois says a reduction in inspections doesn't mean domestically sold meat is less safe. (CBC)

"CFIA officials are candid to us about the reason. It's all about money, or rather, the lack of it," she said.

Kingston said the CFIA has also cut sanitation inspections by 50 per cent and pre-operation inspections by 30 per cent, changes that affect plants producing for both domestic and international markets. He said those changes affect the parts of the process responsible for the majority of outbreaks. 

The problem is not confined to northern Alberta. Meat plants in Calgary and Lethbridge, Alta., often work without enough inspectors to properly inspect the meat, according to the union. Kingston called on the federal government to boost funding for food inspections in the next budget. 

"This government has talked a lot about protecting Canadians," he said. 

"This is serious stuff."

Canadian meat gets 'different attention'

The CFIA said while the number of inspectors may "fluctuate," it spends significantly more on food safety programs since 2008. 

"Inspection work focuses on areas of highest risk first, the areas of focus may change during the year based on emergencies and shifting priorities," the agency wrote in an email sent to CBC News. 

The CFIA went on to say that it isn't unusual for countries to have different inspection standards for imported food, and that differences between Canadian and American standards does not mean Canadians are at risk. 

"It is important to note that differences in inspection procedures are trade related, but not food safety related," it said. 

"In fact, the Conference Board of Canada rates Canada's food safety system number 1 out of 17 Organization for Economic Co-operation and Development (OECD) countries."

Dr. Sylvain Charlebois, a University of Guelph professor who studies food safety, said the changes do not mean Canadian meat is less safe to eat.

"I don't think the health of Canadians has been compromised," he said.

"Canadian-destined meat doesn't get less attention. It just gets different attention."

Charlebois served  on the CFIA's national expert board until 2011. He is currently a member of the Global Food Traceability Center's Advisory Council, based in Washington, D.C.

He said given the CFIA's resources, the agency's changes are the "right way" to approach inspections. Reducing inspections of plants making domestically bound meat was done because the government has confidence in those facilities. Putting resources towards protecting exports is a vital task, he argued.

"That relationship between Canada and the United States is key for our sector, for our economy," he said.

Canada has more than 3,000 food inspectors, Charlebois said, a much higher ratio than what is found in other countries. Instead of hiring more inspectors, he thinks the government should focus on making inspections more transparent.

Keith Warriner, director of the food safety and quality assurance program at the University of Guelph, said the implication that the meat sold in Canada is unsafe is "a little bit of scare-mongering."

He said the union's argument, that fewer inspectors inherently means people are at risk, isn't true. 

"If you had a policeman on every corner, yes, crime might go down," he said. 

"But the better thing is, isn't it, to instill into people not to commit the crime in the first place."

Warriner pointed to events like the 2012 E. coli outbreak centred around beef from the XL Foods plant in Brooks, Alta., which sickened over a dozen people. He said in that case, the plant had enough inspectors, but that they were not doing the work properly. 

He said a much better solution is to get the meat industry to "take ownership" of food safety.

"You can't test your way to food safety. You can't inspect your way to food safety," he said. 

Instead, Warriner would like to see most of the inspection duties being handled by the plants themselves, with federal inspectors looking over a company's internal inspection records. 


22.45 | 0 komentar | Read More

Most hockey helmets fail new safety evaluation

Written By Unknown on Selasa, 31 Maret 2015 | 22.45

Most hockey helmets on the market weren't adequate to reduce the risk of head injuries when an experimental new measurement was used.

When researchers at Virginia Tech's biomedical engineering and mechanics department bought and tested 32 helmets under various impacts, one helmet earned three out of five stars, a "good" rating.

There is no concussion-proof helmet, the researchers stressed. The aim is to have helmet manufacturers lower head acceleration and reduce the risk and number of concussions a player suffers over a season, said study author Stefan Duma, head of Virginia Tech's department of biomedical engineering.

A total of 25 out of 33 helmets tested failed to achieve an "adequate" rating of two stars out of a possible five.

The university's findings included:

  • 1 helmet earned three stars, or "good" — the Warrior Krown 360 ($79.98 US).
  • 6 helmets earned two stars or "adequate" ($34.99 to $159.99 US).
  • 16 helmets earned one star ($26.98 to $269.99 US).
  • 9 helmets earned no star ($39.99 to $119.99 US).
King George kids Howe 3

Cost had no correlation with a helmet's safety rating in the new tests. (CBC News)

The Hockey STAR (summation of tests for the analysis of risks) formula was designed to evaluate helmets based on the rotational acceleration that occurs when the head turns on impact, as well as linear acceleration, or motion in the direction of the impact. Concussion is more related to rotational acceleration, neurosurgeons say.

Currently, helmets and helmet safety standards are designed to protect against injuries such as skull fractures. But better designs are possible, said Duma.

"They are what we took from the football world, where they are a little bigger, they have a larger offset, they have a different style of padding," Duma said. "We're going to be interested to see the consumer acceptance of that, but it is very much possible."

Cost had no correlation with a helmet's safety rating.

The best way to consider the differences in helmets is by acceleration, Duma said.

The STAR formula considers level of impact, which is not the way helmets are currently certified, Alan Ashare, president of the Hockey Equipment Certification Council, told CBC News. Ashare said the council is interested in the research.

Discussing the report in an interview with CBC News, sports medicine physician Dr. Paul Echlin, of Burlington, Ont., stressed the value of educating young players and enforcing non-contact play to reduce impacts.

Changing player behaviour, such as enforcing elbowing penalties, reduces the number of times a player is hit and the likelihood of sustaining a concussion, said Mike Oliver, executive director of the National Operating Committee on Standards for Athletic Equipment.

The independent U.S. group does research and recommends improvement in sports equipment.

Blaine Hoshizaki, chair of the International Standard Committee for ice hockey equipment in Ottawa, took issue with how the measurements were made in the study, suggesting the lab tests don't replicate the variety of impacts encountered in an actual game.

CSA-approved helmets were developed to prevent major fractures and lethal bleeds, Echlin said. But the relationship between helmet design and concussions is unknown.

Hockey Canada spokesman Francis Dupont said it will continue to monitor new research and rely on the expertise of those involved with helmet quality control and the companies responsible for manufacturing helmets.


22.45 | 0 komentar | Read More

Nunavut leads Canada in childhood respiratory illness: pediatrician

Nunavut has a higher rate of young children being admitted to hospital for respiratory illness than the rest of Canada, says an Iqaluit pediatrician.

Dr. Amber Miners, the pediatrician at the Qikiqtani General Hospital, says many cases are related to viruses such as the common cold or RSV (respiratory syncytial virus), which means they can't be treated with antibiotics.

Nunavut also has more children staying in intensive care or being intubated because of such illnesses, Miners said.

"So sometimes if you need oxygen, it's giving oxygen," Miners told CBC News. "Sometimes it's suctioning out the gunk that's in there so they can breathe easier [or] giving them medicine through the [oxygen] mask — not antibiotic medicine, but medicine that opens up the airways and helps them breathe easier."

In 2014, almost half of the 60 pediatric medevacs to Ottawa from Iqaluit were linked to respiratory illness, and 70 per cent of those children were younger than six weeks old.

In 2013, a study published in the International Journal of Circumpolar Health said Inuit children's hospital admissions for respiratory illnesses such as RSV, pneumonia or bronchitis are costing Northern governments millions of dollars.

"I think a lot of it comes down to access to healthy foods, social determinants of health, housing, overcrowding, poverty, those sorts of things overlay all of health in general," said Miners.  

"We do have a high rate of smoking in Nunavut that definitely affects the lungs, both prenatally and postnatally."

In the Northwest Territories, fewer than four per cent of Inuit babies are hospitalized because of a lower respiratory tract infection, while in Nunavut it's almost 25 per cent and, in Nunavik, almost 50 per cent.

The Kitikmeot region had Nunavut's highest rate, with almost 40 per cent of babies admitted to the hospital.


22.45 | 0 komentar | Read More
techieblogger.com Techie Blogger Techie Blogger